{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:32:11Z","timestamp":1790069531488,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Innovative Strong School Project Special Funds of Guangdong Province","award":["B16036098"],"award-info":[{"award-number":["B16036098"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31470236"],"award-info":[{"award-number":["31470236"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81503131"],"award-info":[{"award-number":["81503131"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ejphar.2016.09.009","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T11:41:48Z","timestamp":1473766908000},"page":"473-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Pharmaceutical evaluation of naftopidil enantiomers: Rat functional assays in vitro and estrogen\/androgen induced rat benign prostatic hyperplasia model in vivo"],"prefix":"10.1016","volume":"791","author":[{"given":"Jun-Jun","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Zhen","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia-Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi-Yun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2016.09.009_bib1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1476-5381.1993.tb13534.x","article-title":"Investigation of the subtypes of alpha1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen","volume":"109","author":"Aboud","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.09.009_bib2","first-page":"48","article-title":"Some quantitative uses of drug antagonists","volume":"14","author":"Arunlakshana","year":"1959","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.09.009_bib3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1476-5381.1986.tb10218.x","article-title":"Endothelium-dependent inhibition of platelet aggregation","volume":"88","author":"Azuma","year":"1986","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.09.009_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0014-2999(95)00755-5","article-title":"\u03b11-Adrenoceptor-induced contractility in rat aorta is mediated by the \u03b11D subtype","volume":"297","author":"Buckner","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.09.009_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/iju.13018","article-title":"Effect of 4-chloro-7-trifluoromethyl-10H-benzo[4,5]furo[3,2-b]indole-1-carboxylic acid on the intraurethral pressure in a rat model of benign prostatic hyperplasia","volume":"23","author":"Choi","year":"2016","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.ejphar.2016.09.009_bib7","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0022-5347(05)00367-8","article-title":"Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH)","volume":"175","author":"Di Silverio","year":"2006","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2016.09.009_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00018-009-0174-4","article-title":"Subtypes of functional \u03b11-adrenoceptor","volume":"67","author":"Docherty","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2016.09.009_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/1097-0045(2000)45:9+<4::AID-PROS3>3.0.CO;2-Q","article-title":"Pathology of benign prostatic hyperplasia","volume":"45","author":"Foster","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/j.ejphar.2016.09.009_bib10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1464-410X.2005.05688.x","article-title":"Comparison of tamsulosin and naftopidil for efficacy and safety in the treatment of benign prostatic hyperplasia: a randomized controlled trial","volume":"96","author":"Gotoh","year":"2005","journal-title":"BJU Int."},{"key":"10.1016\/j.ejphar.2016.09.009_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/1097-0045(20001001)45:2<87::AID-PROS2>3.0.CO;2-G","article-title":"Estrogens and prostatic disease","volume":"45","author":"Griffiths","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/j.ejphar.2016.09.009_bib12","series-title":"Animal Models for Benign Prostatic Hyperplasia, in Urinary Tract","first-page":"69","author":"Hieble","year":"2011"},{"key":"10.1016\/j.ejphar.2016.09.009_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00005344-199102000-00006","article-title":"Naftopidil, a new alpha-adrenoceptor blocking agent with calcium antagonistic properties: characterization of Ca2+ antagonistic effects","volume":"17","author":"Himmel","year":"1991","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.09.009_bib14","first-page":"578","article-title":"Design, synthesis and \u03b11-adrenoreceptor blocking activity of new arylpiperazines containing acetophenone substituents","volume":"69","author":"Huang","year":"2014","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejphar.2016.09.009_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejmech.2015.04.005","article-title":"Novel naftopidil-related derivatives and their biological effects as alpha1-adrenoceptors antagonists and antiproliferative agents","volume":"96","author":"Huang","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2016.09.009_bib16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1442-2042.2003.00712.x","article-title":"Usefulness of tamsulosin hydrochloride and naftopidil in patients with urinary disturbances caused by benign prostatic hyperplasia: a comparative, randomized, two-drug crossover study","volume":"10","author":"Kaplan","year":"2003","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.ejphar.2016.09.009_bib17","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/pros.21003","article-title":"Prostate growth inhibition by subtype-selective alpha1\u2010adrenoceptor antagonist naftopidil in benign prostatic hyperplasia","volume":"69","author":"Kojima","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.ejphar.2016.09.009_bib18","first-page":"4550","article-title":"Suppression of human prostate cancer cell growth by \u03b11-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis","volume":"60","author":"Kyprianou","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2016.09.009_bib19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0046-8177(96)90396-2","article-title":"Apoptotic versus proliferative activities in human benign prostatic hyperplasia","volume":"27","author":"Kyprianou","year":"1996","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ejphar.2016.09.009_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jpba.2015.04.034","article-title":"Enantiospecific determination of naftopidil by RRLC\u2013MS\/MS reveals stereoselective pharmacokinetics and tissue distributions in rats","volume":"112","author":"Liu","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejphar.2016.09.009_bib21","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0022-5347(01)62836-2","article-title":"Alpha1-adrenergic receptor subtypes in human detrusor","volume":"160","author":"Malloy","year":"1998","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2016.09.009_bib22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1124\/jpet.115.227066","article-title":"New multi-target antagonists of alpha1A-, alpha1D-Adrenoceptors and 5-HT1A receptors reduce human hyperplastic prostate cell growth and the increase of intraurethral pressure","volume":"356","author":"Nascimento-Viana","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2016.09.009_bib23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.diff.2011.04.006","article-title":"Androgens and estrogens in benign prostatic hyperplasia: past, present and future","volume":"82","author":"Nicholson","year":"2011","journal-title":"Differentiation"},{"key":"10.1016\/j.ejphar.2016.09.009_bib24","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.urology.2008.07.032","article-title":"Effect of naftopidil on nocturia after failure of tamsulosin","volume":"72","author":"Oh-oka","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.ejphar.2016.09.009_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1442-2042.2006.01476.x","article-title":"Estrogens and aspects of prostate disease","volume":"14","author":"Prezioso","year":"2007","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.ejphar.2016.09.009_bib26","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1161\/01.CIR.100.23.2336","article-title":"Subtype specific regulation of human vascular \u03b11-adrenergic receptors by vessel bed and age","volume":"100","author":"Rudner","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2016.09.009_bib27","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0022-5347(17)37546-8","article-title":"The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia","volume":"147","author":"Shapiro","year":"1992","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2016.09.009_bib28","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1021\/jo062674j","article-title":"Zinc (II) Perchlorate hexahydrate catalyzed opening of epoxide ring by amines: applications to synthesis of (RS)\/(R)-propranolols and (RS)\/(R)\/(S)-naftopidils","volume":"72","author":"Shivani, Pujala","year":"2007","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejphar.2016.09.009_bib29","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/00005344-199212000-00023","article-title":"Naftopidil, a new adrenoceptor blocking agent with Ca2+-antagonistic properties: interaction with adrenoceptors","volume":"20","author":"Sponer","year":"1992","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.09.009_bib30","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0024-3205(79)90505-8","article-title":"pA2 and receptor differentiation: a statistical analysis of competitive antagonism","volume":"25","author":"Tallarida","year":"1979","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2016.09.009_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.exger.2004.12.008","article-title":"Benign prostatic hyperplasia: age-related tissue-remodeling","volume":"40","author":"Untergasser","year":"2005","journal-title":"Exp. Gerontol."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2016.09.009_bib32","first-page":"7","article-title":"Medical therapy for benign prostatic hyperplasia: a review","volume":"22","author":"Van Asseldonk","year":"2015","journal-title":"Can. J. Urol."},{"key":"10.1016\/j.ejphar.2016.09.009_bib33","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/iju.12156","article-title":"Reduction of prostate cancer incidence by naftopidil, an \u03b11-adrenoceptor antagonist and transforming growth factor-\u03b2 signaling inhibitor","volume":"20","author":"Yamada","year":"2013","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.ejphar.2016.09.009_bib34","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/aja.2010.24","article-title":"Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia","volume":"12","author":"Yang","year":"2010","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.ejphar.2016.09.009_bib35","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1021\/acs.jmedchem.5b02023","article-title":"Design, synthesis, and biological evaluation of indoline and indole derivatives as potent and selective \u03b11A-Adrenoceptor antagonists","volume":"59","author":"Zhao","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2016.09.009_bib36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/aja.2009.28","article-title":"Proliferation and phenotypic changes of stromal cells in response to varying estrogen\/androgen levels in castrated rats","volume":"11","author":"Zhou","year":"2009","journal-title":"Asian J. Androl."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916305854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916305854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T03:41:35Z","timestamp":1572579695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299916305854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":35,"alternative-id":["S0014299916305854"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.09.009","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmaceutical evaluation of naftopidil enantiomers: Rat functional assays in vitro and estrogen\/androgen induced rat benign prostatic hyperplasia model in vivo","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}